Home »
Experiments in mice have shown early success in vaccinating them against potentially deadly bacterial infections, such as methicillin-resistant Staphylococcal aureus, or MRSA, the strain resistant to most drug treatments. The new vaccination strategy, developed by
In a new analysis of SARS-CoV-2, the virus that causes COVID-19, test results for nearly 38,000 people has found a positivity rate among Latinx populations about three times higher than for any other racial and
Scientists at City of Hope, working in collaboration with researchers at Translational Genomics Research Institute (TGen) and other colleagues across the country, have found that the actions of circulating immune cells—namely how they differentiate and
The news that children currently face may seem almost unspeakable. But, together, we must find words, and ways, to give voice to their experience and prevent millions of children struggling with their fears and uncertainty alone. Research shows that sensitive and effective communication
Ebola, measles, and COVID-19 – dangerous eruptions in the Congo In the democratic Republic of the Congo (DRC), there is a new Ebola outbreak. At the same time, the new Coronavirus is circulating and that
If you’re not quite living your best life at this particular moment in time, Julianne Hough understands — and she’s here to help. The multi-hyphenate star (Hough is an actor, singer, and of course, dancer —
An analysis of 13,000 tumors highlights two previously overlooked genes as potential new therapeutic targets for cancer treatment. The researchers have also identified potential new therapeutic targets for male infertility. Both findings are the result
Selma Blair posted a new video to Instagram showing herself walking with new braces on her legs. Selma was diagnosed with multiple sclerosis in 2018. She’s previously posted photos and video of herself walking with
Scientists have discovered a potential new treatment for a disease that causes severe dry eyes and dry mouth. The study, led by researchers at RCSI University of Medicine and Health Sciences, is published in the
An initial trial in patients indicates that a new genetic treatment for complete color blindness, developed by research groups based in Tübingen and Munich is safe. Preliminary evidence for its efficacy has also been obtained.